GlobalData’s director of therapy research & analysis in medical devices says the new entity could make an attractive ...

CEO Tom Polen said BD will “double down on shifting our portfolio, both organically and inorganically through tuck-in M&A, ...

In addition to the main racing event, test-drive opportunities were provided for enthusiasts, allowing hundreds of visitors to experience motorcycles from Royal Enfield, CF Motors, and Yamaha.

Wells Fargo lowered the firm’s price target on Becton Dickinson (BDX) to $270 from $275 and keeps an Overweight rating on the shares. The firm ...

Piper Sandler analyst Jason Bednar maintained a Buy rating on Becton Dickinson (BDX – Research Report) today and set a price target of $280.00.

Greg Rodetis; Senior Vice President, Treasurer and Head of Investor Relations; Becton Dickinson and Co Thomas Polen; Chairman of the Board, President, Chief Executive Officer; Becton Dickinson and Co ...

Becton Dickinson & Co. closed 9.83% short of its 52-week high of $251.99, which the company reached on February 3rd.

The board of directors of Franklin Lakes-based, global medical technology company BD, has unanimously authorized BD management ...